Investor Overview
Company Profile
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney disease and acute ischemic stroke. DiaMedica's shares are listed on The Nasdaq Capital Market under the trading symbol "DMAC."
-
Go to Detailed Stock Information ›
Nasdaq Stock Snapshot
DMAC
Symbol
Nasdaq
Market
--
Volume
--
Price
--
Change
Upcoming Events
Release of Full Year 2018 Results and Conference Call
View IR Calendar ›
Conference Call details:
| Date: | March 20, 2019 |
| Time: | 8:00 AM CT |
| Web access: | https://edge.media-server.com/m6/p/idbwv4bq |
| Dial In: | (866) 962-3583 (domestic) |
| (630) 652-5857 (international) | |
| Conference ID: | 6773627 |
Conference Call